QT Imaging Holdings, Inc. (NASDAQ:QTI) Stock Now Rated “Hold” by Sell-Side Brokerages

QT Imaging Holdings, Inc. (NASDAQ:QTI) has earned an average recommendation of “Hold” from the five ratings firms that are currently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and three have issued a buy recommendation on the company. The average 1-year price objective among brokers that have covered the stock in the last year is $8.50.

A number of equities analysts have recently issued reports on QTI shares. Weiss Ratings restated a “sell (e+)” rating on shares of QT Imaging in a research report on Tuesday, October 6th. D. Boral Capital started coverage on shares of QT Imaging in a report on Friday. They issued a “buy” rating and a $9.00 price target on the stock. Finally, Craig Hallum began coverage on QT Imaging in a report on Monday, October 5th. They set a “buy” rating and a $8.00 price target on the stock.

QT Imaging Trading Down 4.7%

QTI stock traded down $0.11 during midday trading on Friday, reaching $2.25. The company’s stock had a trading volume of 41,732 shares, compared to its average volume of 40,892. QT Imaging has a 1 year low of $2.25 and a 1 year high of $8.50. The company has a debt-to-equity ratio of 6.81, a quick ratio of 2.06 and a current ratio of 3.10. The stock has a fifty day simple moving average of $2.67 and a two-hundred day simple moving average of $3.97. The firm has a market capitalization of $30.98 million, a price-to-earnings ratio of -1.43 and a beta of 0.02.

QT Imaging (NASDAQ:QTI) last posted its quarterly earnings results on Wednesday, August 12th. The company reported ($0.75) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.22) by ($0.53). QT Imaging had a negative return on equity of 1,202.69% and a negative net margin of 77.25%. The company had revenue of $7.44 million during the quarter, compared to analysts’ expectations of $7.60 million. On average, equities research analysts predict that QT Imaging will post -1.11 EPS for the current year.

Institutional Investors Weigh In On QT Imaging

Several institutional investors and hedge funds have recently made changes to their positions in the company. Stonepine Capital Management LLC bought a new stake in QT Imaging in the second quarter valued at about $407,000. Polar Asset Management Partners Inc. bought a new stake in shares of QT Imaging in the second quarter valued at approximately $210,000. Finally, BlackRock Inc. boosted its stake in QT Imaging by 116.5% in the second quarter. BlackRock Inc. now owns 61,353 shares of the company’s stock valued at $250,000 after buying an additional 33,009 shares in the last quarter. Institutional investors and hedge funds own 24.19% of the company’s stock.

About QT Imaging

QT Imaging Holdings, Inc develops medical imaging technology designed to support breast cancer screening and diagnostic procedures. The company’s flagship product, QTscan, is a three-dimensional, transmission-based breast imaging system that uses ultrasound technology to produce images without ionizing radiation, breast compression or injectable contrast agents.

QTscan is intended for use by healthcare providers as an imaging tool for evaluating breast tissue, including in patients with dense breasts.